Steep cuts at the Food and Drug Administration might slow down drug approvals vital to the biopharma industry.
Sanofi’s treatment for hemophilia that can be administered as infrequently as once every other month, was approved by the US ...
Shares of Solano Therapeutics are surging after winning US FDA approval for its new drug to treat excessive hunger and people with Prader-Willi syndrome, a genetic disorder that leads to physical ...
U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and deadly heart disease on Thursday, allowing the ...
Researchers analyzed pivotal and confirmatory trial characteristics, outcomes, and safety data for 102 cancer drug ...
The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...
The increasing prevalence of drug-resistant bacteria contributing to UTIs has highlighted the need for new treatment options,” GSK said. The FDA's approval ... may pay us to be Authorized ...
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
Over the last three years, the FDA has approved six new hemophilia drugs, including three gene therapies. | Over the last ...
The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
US FDA Expands Approval for Alnylam's Drug to Treat Rare Heart Disease By Bhanvi Satija and Sneha S K (Reuters) -U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and ...